Response of human renal tubular cells to cyclosporine and sirolimus: A toxicogenomic study

Toxicology and Applied Pharmacology

Volumn 229, Issue 2, 2008, Pages 184-196

  Pallet, Nicolas ^a   Rabant, Marion ^a   Xu Dubois, Yi Chun ^a   LeCorre, Delphine ^a   Mucchielli, Marie Hélène ^b   Imbeaud, Sandrine ^b   Agier, Nicolas ^b   Hertig, Alexandre ^a   Thervet, Eric ^c   Legendre, Christophe ^c   Beaune, Philippe ^a   Anglicheau, Dany ^a,c  

^a INSERM   (France)

^b CNRS   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cyclosporine; Endoplasmic reticulum stress; Sirolimus; Transcriptome; Tubular cells

Indexed keywords

CYCLOSPORIN; RAPAMYCIN;

ARTICLE; CELL ACTIVITY; CELL MEMBRANE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; GENE CLUSTER; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; ION TRANSPORT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY TUBULE CELL; MOLECULAR INTERACTION; SIGNAL TRANSDUCTION; TOXICOGENETICS; TREATMENT RESPONSE; UPREGULATION;

BASE SEQUENCE; CELLS, CULTURED; CYCLOSPORINE; DNA PRIMERS; GENOMICS; HUMANS; KIDNEY TUBULES; POLYMERASE CHAIN REACTION; SIROLIMUS;

EID: 43449132085     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.01.019     Document Type: Article

References (46)

1. Anglicheau D., Pallet N., Rabant M., Marquet P., Cassinat B., Meria P., Beaune P., Legendre C., and Thervet E. Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction. Kidney Int. 70 (2006) 1019-1025
2. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
3. Bosco M.C., Puppo M., Santangelo C., Anfosso L., Pfeffer U., Fardin P., Battaglia F., and Varesio L. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J. Immunol. 177 (2006) 1941-1955
4. Burdmann E.A., Andoh T.F., Yu L., and Bennett W.M. Cyclosporine nephrotoxicity. Semin. Nephrol. 23 (2003) 465-476
5. Cole E., Midtvedt K., Johnston A., Pattison J., and O'Grady C. Recommendations for the implementation of Neoral C(2) monitoring in clinical practice. Transplantation 15 (2002) S19-S22
6. Campistol J.M., and Sacks S.H. Mechanisms of nephrotoxicity. Transplantation 69 (2000) SS5-SS10
7. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 (2003) P3
8. DeRisi J., Penland L., Brown P.O., Bittner M.L., Meltzer P.S., Ray M., Chen Y., Su Y.A., and Trent J.M. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14 (1996) 457-460
9. Eddy A.A., and Neilson E.G. Chronic kidney disease progression. J. Am. Soc. Nephrol. 17 (2006) 2964-2966
10. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14863-14868
11. Flechner S.M., Kurian S.M., Solez K., Cook D.J., Burke J.T., Rollin H., Hammond J.A., Whisenant T., Lanigan C.M., Head S.R., and Salomon D.R. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am. J. Transplant. 4 (2004) 1776-1785
12. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351 (2004) 2715-2729
13. Herrero-Fresneda I., Torras J., Franquesa M., Vidal A., Cruzado J.M., Lloberas N., Fillat C., and Grinyo J.M. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int. 70 (2006) 265-274
14. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., and Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110 (2002) 341-350
15. Joly D., Morel V., Hummel A., Ruello A., Nusbaum P., Patey N., Noel L.H., Rousselle P., and Knebelmann B. Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am. J. Pathol. 163 (2003) 1791-1800
16. Kahan B.D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 356 (2000) 194-202
17. Kanehisa M., and Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000) 27-30
18. Klipper-Aurbach Y., Wasserman M., Braunspiegel-Weintrob N., Borstein D., Peleg S., Assa S., Karp M., Benjamini Y., Hochberg Y., and Laron Z. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med. Hypotheses 45 (1995) 486-490
19. Kreis H., Cisterne J.M., Land W., Wramner L., Squifflet J.P., Abramowicz D., Campistol J.M., Morales J.M., Grinyo J.M., Mourad G., Berthoux F.C., Brattstrom C., Lebranchu Y., and Vialtel P. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 69 (2000) 1252-1260
20. Kreis H., Oberbauer R., Campistol J.M., Mathew T., Daloze P., Schena F.P., Burke J.T., Brault Y., Gioud-Paquet M., Scarola J.A., and Neylan J.F. Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. J. Am. Soc. Nephrol. 15 (2004) 809-817
21. Li Y., Wen X., Spataro B.C., Hu K., Dai C., and Liu Y. Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. J. Am. Soc. Nephrol. 17 (2006) 54-65
22. Lin W., Bailey S.L., Ho H., Harding H.P., Ron D., Miller S.D., and Popko B. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117 (2007) 448-456
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
24. MacDonald A.S. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 71 (2001) 271-280
25. McMorrow T., Gaffney M.M., Slattery C., Campbell E., and Ryan M.P. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol. Dial. Transplant. 20 (2005) 2215-2225
26. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101 (2000) 451-454
27. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., and Chapman J.R. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326-2333
28. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Chapman J.R., and Allen R.D. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 78 (2004) 557-565
29. Nankivell B.J., and Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 81 (2006) 643-654
30. Ong A.C., and Fine L.G. Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am. J. Kidney Dis. 23 (1994) 205-209
31. Pallet N., Thervet E., Le Corre D., Knebelmann B., Nusbaum P., Tomkiewicz C., Meria P., Flinois J.P., Beaune P., Legendre C., and Anglicheau D. Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. Kidney Int. 67 (2005) 2422-2433
32. Peng X., Wood C.L., Blalock E.M., Chen K.C., Landfield P.W., and Stromberg A.J. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4 (2003) 26
33. Podder H., Stepkowski S.M., Napoli K.L., Clark J., Verani R.R., Chou T.C., and Kahan B.D. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J. Am. Soc. Nephrol. 12 (2001) 1059-1071
34. Rebhan M., Chalifa-Caspi V., Prilusky J., and Lancet D. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 14 (1998) 656-664
35. Ron D. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. 110 (2002) 1383-1388
36. Shihab F.S., Andoh T.F., Tanner A.M., Yi H., and Bennett W.M. Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int. 56 (1999) 2147-2159
37. Shihab F.S., Bennett W.M., Yi H., Choi S.O., and Andoh T.F. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity. Kidney Int. 65 (2004) 1262-1271
38. Slattery C., Campbell E., McMorrow T., and Ryan M.P. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am. J. Pathol. 167 (2005) 395-407
39. Smyth G.K., and Speed T. Normalization of cDNA microarray data. Methods 31 (2003) 265-273
40. Straathof-Galema L., Wetzels J.F., Dijkman H.B., Steenbergen E.J., and Hilbrands L.B. Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism. Am. J. Transplant. 6 (2006) 429-433
41. Wen X., Li Y., Hu K., Dai C., and Liu Y. Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am. J. Pathol. 167 (2005) 947-957
42. Xiang C.C., and Chen Y. cDNA microarray technology and its applications. Biotechnol. Adv. 18 (2000) 35-46
43. Xu C., Bailly-Maitre B., and Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115 (2005) 2656-2664
44. Yamashita S., Maeshima A., Kojima I., and Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J. Am. Soc. Nephrol. 15 (2004) 91-101
45. Zeisberg M., Strutz F., and Muller G.A. Renal fibrosis: an update. Curr. Opin. Nephrol. Hypertens. 10 (2001) 315-320
46. Zhang K., and Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J. Biol. Chem. 279 (2004) 25935-25938